| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |